| Features: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Hydrogen Gas, Powerful Antioxidant Mechanistically, H₂ is most defensibly framed as a selective antioxidant + anti-inflammatory signaling modulator (often via Nrf2↑ and NF-κB↓ / NLRP3↓), with strongest clinical relevance in oncology being reduction of treatment toxicities (radiation/CCRT side-effects), with mixed/early evidence for direct anticancer effects. 1.Antioxidant and Nrf2/ARE Pathway: activate Nrf2, which induces antioxidant enzymes. 2.NF-κB Pathway: reported to inhibit NF-κB activation, thereby reducing inflammatory cytokine production 3.Mitochondrial Apoptosis Pathway 4.MAPK (Mitogen-Activated Protein Kinases) Pathway 5.PI3K/Akt/mTOR Pathway 6.Inflammatory Cytokine Signaling: Reducing cytokines (such as IL-6, TNF-α) 7.p53 Pathway 8.Autophagy Pathways: might regulate autophagy, (dual roles in cancer) Example unit sometimes used in studies Example Canadian Supplier Hydrogen gas can be generated in small amount by hydrogenase of certain members of the human gastrointestinal tract microbiota from unabsorbed carbohydrates in the intestine through degradation and metabolism, which then is partially diffused into blood flow and released and detected in exhaled breath, indicating its potential to serve as a biomarker. Many studies have shown that H2 therapy can reduce oxidative stress. This, however, contradicts radiation therapy and chemotherapy, in which ROS are required to induce apoptosis and combat cancer. Yet many studies show chemoprotective and radioprotective and some even show chemosentizing Nevertheless there are some papers claiming ROS ↑ for cancer cells Hydrogen Gas in Water is also used. - the amount of H2 dissolved in solutions is limited: up to 0.8 mM (1.6 mg/L) H2 can be dissolved in water under atmospheric pressure at room temperature Hydrogen Gas — molecular hydrogen (H₂) is a small, neutral diatomic gas investigated as a therapeutic medical gas and redox-signaling modulator. It rapidly diffuses across biological membranes and can be administered by inhalation or indirectly as hydrogen-rich water (HRW), hydrogen-rich saline, or hydrogen-releasing materials. H₂ is best classified as an experimental therapeutic gas rather than a conventional antioxidant drug. Standard abbreviations are H₂ for molecular hydrogen and HRW for hydrogen-rich water. Endogenous H₂ is also produced by intestinal microbial fermentation. Its biological effects appear to involve modulation of oxidative stress, inflammation, mitochondrial function, cell-death signaling, and immune metabolism rather than indiscriminate ROS scavenging alone. Primary mechanisms (ranked):
Bioavailability / PK relevance: H₂ has unusually rapid tissue diffusion because of its very small, nonpolar structure, but tissue exposure is transient because hydrogen is rapidly redistributed and exhaled. Inhalation provides continuing systemic exposure during administration, whereas HRW delivers a comparatively small finite H₂ dose that falls rapidly after preparation and ingestion. At approximately atmospheric pressure and room temperature, water saturation is only about 1.6 mg/L H₂, approximately 0.8 mmol/L. Biological efficacy therefore depends strongly on route, concentration, treatment duration, and proximity of H₂ generation to the target tissue. In-vitro vs systemic exposure relevance: H₂ does not behave like a conventional concentration-maintained small-molecule drug. Gas-equilibrated cell culture can provide sustained H₂ exposure that is difficult to reproduce with a single oral dose of HRW. Conversely, inhalation can continuously replenish dissolved H₂ during treatment. Results from prolonged gas-equilibrated cultures, high-pressure systems, or locally generated H₂ nanomaterials should therefore not automatically be extrapolated to ordinary hydrogen-water exposure. Clinical evidence status: Small human studies and randomized adjunctive trials exist, but H₂ is not an established anticancer therapy. The most credible oncology application currently is supportive treatment during chemotherapy or radiotherapy. A 2025 randomized study in cervical-cancer patients receiving concurrent chemoradiotherapy reported reduced acute radiation enteritis and inflammatory responses with adjunctive H₂/O₂ inhalation without an apparent reduction in tumor-control efficacy. Direct antitumor evidence remains predominantly preclinical, observational, or derived from small uncontrolled cancer cohorts. Trials of HRW during glioma radiochemotherapy and other indications remain exploratory. H₂ should therefore be classified as experimental adjunct/supportive therapy rather than standalone cancer treatment. Hydrogen Gas Cancer-Relevant Mechanisms
P: 0–30 min R: 30 min–3 hr G: >3 hr Hydrogen Gas and Alzheimer’s disease: Molecular hydrogen has substantial preclinical neuroprotective evidence and limited early human evidence in Alzheimer’s disease and mild cognitive impairment. Proposed mechanisms include oxidative-stress suppression, neuroinflammation reduction, mitochondrial protection, BDNF-related signaling, and reductions in Aβ/BACE-associated pathology and tau phosphorylation. H₂ readily diffuses into the CNS, making delivery biologically plausible, but clinical evidence remains insufficient to classify it as a disease-modifying AD treatment. Clinical evidence status: Preclinical evidence is extensive relative to the small clinical literature. Human studies include an open-label inhalation pilot in AD, a single-arm biomarker study, and a randomized hydrogen-rich-water study in mild cognitive impairment. Reported cognitive or biomarker improvements are hypothesis-generating; adequately powered randomized trials with validated AD endpoints are still needed. Hydrogen Gas Alzheimer-Relevant Mechanisms
P: 0–30 min R: 30 min–3 hr G: >3 hr |
| Source: |
| Type: |
| Creatinine is fundamentally a metabolic waste product derived from creatine phosphate in muscle. Its blood levels are routinely used as a clinical biomarker to assess kidney function rather than a direct regulator of oncogenic processes. Creatinine is a primary marker used to estimate the glomerular filtration rate (GFR). -Elevated creatinine can be a sign of compromised kidney vascular function. |
| 7482- | H2, | Molecular Hydrogen Therapy: Mechanisms, Delivery Methods, Preventive, and Therapeutic Application |
| - | Review, | Var, | NA | - | Review, | IBD, | NA | - | Review, | Stroke, | NA | - | Review, | Sepsis, | NA | - | Review, | AD, | NA |
| 7483- | H2, | Cisplatin, | Molecular hydrogen attenuates cisplatin-induced nephrotoxicity by modulating β-hydroxybutyrate metabolism |
| - | in-vivo, | Nor, | HK-2 |
| 7492- | H2, | Chemo, | Molecular Hydrogen Protects against Various Tissue Injuries from Side Effects of Anticancer Drugs by Reducing Oxidative Stress and Inflammation |
| - | Review, | Var, | NA |
| 4126- | Silicon, | H2, | Oral Administration of Si-Based Agent Attenuates Oxidative Stress and Ischemia-Reperfusion Injury in a Rat Model: A Novel Hydrogen Administration Method |
| - | in-vivo, | NA, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:295 Target#:1251 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid